Labcorp Holdings Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: Election of the members of the Company's Board of Directors: Adam H. Schechter

Labcorp Holdings Inc.’s own tally for this item (“Elect Director: Adam H. Schechter”): 65,401,337 for, 4,958,626 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2027 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 163 asset managers below reported 32,698,077 for, 82 against, 1,837 abstained, 70 not voted.

Showing the 25 largest of 163 asset managers. See all 163 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Garheng Kong, M.D., Ph.D.

Labcorp Holdings Inc.’s own tally for this item (“Elect Director: Garheng Kong, M.D., Ph.D.”): 50,153,535 for, 20,110,931 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2027 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 71% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 163 asset managers below reported 25,358,397 for, 7,339,758 against, 1,842 abstained, 70 not voted.

Showing the 25 largest of 163 asset managers. See all 163 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Jeffrey A. Davis

Labcorp Holdings Inc.’s own tally for this item (“Elect Director: Jeffrey A. Davis”): 70,478,919 for, 56,436 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2027 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 163 asset managers below reported 32,698,158 for, 1,837 abstained, 70 not voted.

Showing the 25 largest of 163 asset managers. See all 163 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: John H. Sampson, M.D., Ph.D.

Labcorp Holdings Inc.’s own tally for this item (“Elect Director: John H. Sampson, M.D., Ph.D.”): 70,465,205 for, 70,221 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2027 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 163 asset managers below reported 32,698,158 for, 1 against, 1,837 abstained, 70 not voted.

Showing the 25 largest of 163 asset managers. See all 163 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Kathryn E. Wengel

Labcorp Holdings Inc.’s own tally for this item (“Elect Director: Kathryn E. Wengel”): 70,186,853 for, 348,897 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2027 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 163 asset managers below reported 32,698,154 for, 5 against, 1,837 abstained, 70 not voted.

Showing the 25 largest of 163 asset managers. See all 163 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Kerrii B. Anderson

Labcorp Holdings Inc.’s own tally for this item (“Elect Director: Kerrii B. Anderson”): 65,239,780 for, 5,292,331 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2027 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 163 asset managers below reported 31,747,157 for, 951,001 against, 1,837 abstained, 70 not voted.

Showing the 25 largest of 163 asset managers. See all 163 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Kirsten M. Kliphouse

Labcorp Holdings Inc.’s own tally for this item (“Elect Director: Kirsten M. Kliphouse”): 70,499,628 for, 36,211 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2027 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 163 asset managers below reported 32,698,158 for, 1,837 abstained, 70 not voted.

Showing the 25 largest of 163 asset managers. See all 163 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Paul B. Rothman, M.D.

Labcorp Holdings Inc.’s own tally for this item (“Elect Director: Paul B. Rothman, M.D.”): 70,194,447 for, 340,176 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2027 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 163 asset managers below reported 32,698,154 for, 5 against, 1,837 abstained, 70 not voted.

Showing the 25 largest of 163 asset managers. See all 163 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Peter M. Neupert

Labcorp Holdings Inc.’s own tally for this item (“Elect Director: Peter M. Neupert”): 65,976,598 for, 4,555,882 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2027 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 163 asset managers below reported 31,797,864 for, 900,294 against, 1,837 abstained, 70 not voted.

Showing the 25 largest of 163 asset managers. See all 163 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Richelle P. Parham

Labcorp Holdings Inc.’s own tally for this item (“Elect Director: Richelle P. Parham”): 67,776,302 for, 2,757,710 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2027 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 163 asset managers below reported 32,573,942 for, 124,217 against, 1,837 abstained, 70 not voted.

Showing the 25 largest of 163 asset managers. See all 163 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Victor Bulto

Labcorp Holdings Inc.’s own tally for this item (“Elect Director: Victor Bulto”): 70,498,948 for, 34,977 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2027 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 163 asset managers below reported 32,698,158 for, 1,837 abstained, 70 not voted.

Showing the 25 largest of 163 asset managers. See all 163 in the interactive database.

Description as filed by funds: TO APPROVE, BY NON-BINDING VOTE, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

Labcorp Holdings Inc.’s own tally for this item (“2. In an advisory (non-binding) vote, the compensation of the Company's named executive officers”): 66,519,291 for, 3,735,777 against — passed, per its Form 8-K filed May 26, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's shareholders approved in an advisory (non-binding) vote, the compensation of the Company's named executive officers.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 158 managers: 32,373,565 for, 306,150 against, 1,842 abstained, 70 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 820 managers: 46,972,509 for, 1,936,435 against, 238,776 abstained, 34,752 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratification of the appointment of Deloitte and Touche LLP as Labcorp Holdings Inc.'s independent registered public accounting firm for the year ending December 31, 2026.

Labcorp Holdings Inc.’s own tally for this item (“3. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026”): 76,291,589 for, 53,650 against — passed, per its Form 8-K filed May 26, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's shareholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 164 asset managers below reported 32,702,159 for, 1,837 abstained, 70 not voted.

Showing the 25 largest of 164 asset managers. See all 164 in the interactive database.